← Back to Search

Skincare Product Treatment for Psoriasis

Phase 4

Recruiting

Led By Zoe D Draelos, MD

Research Sponsored by Galderma R&D

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 2, week 4, week 8

Awards & highlights

Study Summary

"This trial will test the effectiveness of a skincare regimen for people with plaque psoriasis by having them apply the treatment to one side of their body. Researchers will evaluate the results after 2 weeks,

Who is the study for?

This trial is for individuals with mild-to-severe plaque psoriasis who are currently using or starting a prescription treatment. Participants will apply a topical skincare regimen to one side of their body.Check my eligibility

What is being tested?

The study tests the effectiveness and tolerability of Cetaphil as a skincare product on patients with plaque psoriasis. The efficacy is evaluated at intervals over an 8-week period.See study design

What are the potential side effects?

While not explicitly stated, typical side effects from topical products like Cetaphil may include skin irritation, redness, itching, or allergic reactions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 2, week 4, week 8

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 2, week 4, week 8

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 2, week 4, week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in psoriatic Body Surface Area compared to baseline

Change in skin quality measured by macroscopic imaging

Change in target lesion severity compared to baseline

+3 more

Secondary outcome measures

Subject Quality of Life Satisfaction

Trial Design

1Treatment groups

Experimental Treatment

Group I: Skincare Product TreatmentExperimental Treatment1 Intervention

Subjects will use topical skincare products to assigned side of the body, per randomization.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cetaphil

2014

Completed Phase 4

~80

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Galderma R&DLead Sponsor

299 Previous Clinical Trials

60,370 Total Patients Enrolled

18 Trials studying Psoriasis

4,312 Patients Enrolled for Psoriasis

Zoe D Draelos, MDPrincipal InvestigatorDermatology Consulting Services, High Point NC

5 Previous Clinical Trials

249 Total Patients Enrolled

1 Trials studying Psoriasis

20 Patients Enrolled for Psoriasis

George F Hougeir, MDPrincipal InvestigatorSoutheast Dermatology Specialist, LLC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment phase of this medical study currently accepting participants?

"As documented on clinicaltrials.gov, this research endeavor is presently in search of eligible participants. The trial was initially made public on April 8th, 2024, with the most recent update noted on April 9th, 2024."

Answered by AI

What is the current number of participants enrolled in this research study?

"Indeed, the details on clinicaltrials.gov specify that this study is actively seeking eligible participants. The trial was initially posted on April 8th, 2024 and last modified on April 9th, 2024. Recruitment aims to enroll a total of 50 individuals distributed across three designated locations."

Answered by AI

Has this skincare product been granted approval by the FDA for its treatment properties?

"Rated at 3 on the scale, our team at Power affirms that Skincare Product Treatment is deemed safe as it enters Phase 4, indicating regulatory approval."

Answered by AI